Oxford Drug Design is proud to have been shortlisted for this year’s CogX award for ‘Best AI product in health’.

CogX is an annual festival of AI and emerging tech that brings together leaders, entrepreneurs, and policy makers from all sectors to address the problems of the future.

CognitionX aims to educate and promote AI across all organisations and help ensure a safe and responsible transition to an AI-driven society.